av/aptinyx--big.svg

NASDAQ:APTX

Aptinyx Inc.

  • Stock

USD

Last Close

0.09

29/12 20:59

Market Cap

6.50M

Beta: 1.33

Volume Today

231.13K

Avg: 3.59M

PE Ratio

−0.59

PFCF: −0.16

OverviewFinancialsAPI

    Description

    Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders. The company is developing NYX-2925, which is in Phase II clinical development for the treatment of painful diabetic peripheral neuropathy, as well as i...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    -2-1.5-1-0.52017-03-312018-11-132020-05-142022-03-232023-09-28

    Revenue (Estimate*)

    500K1M1.50M2M2.50M3M3.50M2017-03-312018-11-132020-05-142022-03-232023-09-28

    *Estimate based on analyst consensus